Evaluation of Immunogenicity and Safety of Combined Immunization of COVID-19 Vaccine (Produced in Beijing) and PPV23 / IIV4
Clinical trial NCT04790851 · COMPLETED
Trial details
- NCT number
- NCT04790851
- Sponsor
- China National Biotec Group Company Limited
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-10
- Primary completion
- 2021-09-05
- Enrollment
- 1133
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.